Universal Nutriscience completes acquisition of nutraceuticals business from Sanofi India

Universal Nutriscience on Thursday said it has completed the acquisition of the nutraceuticals business from Sanofi India.

The company has completed "the acquisition of all assets pertaining to the nutraceuticals business of Sanofi India Ltd (SIL) through a slump sale process," Universal Nutriscience (UNS) said in a statement.

The complete nutraceutical portfolio consisting of 16 brands, including market leaders such as Seacod, ECod, CoQ, Primosa, Collaflex, along with most of the employees engaged in the marketing and distribution of these brands, have been seamlessly transferred to Universal Nutriscience effective September 30, 2021, it added.

"I am delighted that UNS is focused exclusively on Nutraceuticals and has the necessary resources, the drive, and the vision to become the country's leading Nutraceutical and Wellness company," Chairman of the Board of Directors - UNS, Shailesh Ayyangar said.

FPJ Shorts

Disha Salian Death Case: 5 Years On, Investigation Still Delayed Amid Political Claims And Ongoing Legal Challenges

Disha Salian Death Case: Bombay HC Seeks Medical Reports Before Considering Plea For FIR; State Awaiting Fresh Forensic Findings

Bombay HC Questions ‘Malafide’ In Scaling Down Zeeshan Siddique’s Security After Father Baba Siddique’s Murder; Seeks Committee Records

Bombay HC Quashes Case Against Chanda Kochhar, 4 ICICI Officials In PMC Octroi Evasion Row; Proceedings To Continue Against Bank

Universal Nutriscience Pvt Ltd is a partnership between Kedaara Capital and Universal Medicare.